Follow
Mylan Blomquist
Mylan Blomquist
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma
BG Harder, MR Blomquist, J Wang, AJ Kim, GF Woodworth, JA Winkles, ...
Frontiers in oncology 8, 462, 2018
1482018
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression
MR Blomquist, SF Ensign, F D’Angelo, JJ Phillips, M Ceccarelli, S Peng, ...
Neuro-oncology advances 2 (1), vdaa078, 2020
172020
Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures
LS Hu, F D’Angelo, TM Weiskittel, FP Caruso, SP Fortin Ensign, ...
Nature communications 14 (1), 6066, 2023
72023
A novel transcriptional complex of OLIG2-STAT5 mediates glioma stem cell self renewal and invasion
A Miller, C Lo Cascio, M Blomquist, JB McNamara, K Orndorff, M Dufault, ...
Cancer Research 84 (6_Supplement), 256-256, 2024
2024
EGFR missense mutation (s) induce OLIG2 expression to regulate glioma stem cells maintenance and therapeutic resistance
S Weaver, A Miller, M Blomquist, J McNamara, K Orndorff, C Sereduk, ...
Cancer Research 84 (6_Supplement), 5444-5444, 2024
2024
EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in Glioblastoma
MR Blomquist, R Eghlimi, A Beniwal, D Grief, DG Nascari, L Inge, ...
International Journal of Molecular Sciences 25 (11), 6279, 2024
2024
STAT5-OLIG2 TRANSCRIPTIONAL COMPLEX MEDIATES GLIOMA STEM CELL SELF RENEWAL AND INVASION
A Miller, C Lo Cascio, M Blomquist, J McNamara, K Orndorff, M Dufault, ...
NEURO-ONCOLOGY 25, 2023
2023
REGULATION OF GLIOMA STEM CELL MAINTENANCE AND THERAPEUTIC RESISTANCE BY EGFR MISSENSE MUTATIONS
S Weaver, A Miller, M Blomquist, J McNamara, K Orndorff, J Kloss, ...
NEURO-ONCOLOGY 25, 2023
2023
INNV-20. PREDICTING RESPONSE TO CHEMOTHERAPY IN HIGH GRADE GLIOMAS USING EX VIVO 3D CELL CULTURE FUNCTIONAL PRECISION …
M Mrugala, M Hrachova, W Sherman, SF Ensign, M Blomquist, A Porter, ...
Neuro-Oncology 25 (Supplement_5), v160-v161, 2023
2023
The following chapter presents a portion of the study “Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures …
M Blomquist, LS Hu, F D’Angelo, T Weiskittel, F Pia
TARGETING RECURRENCE IN GLIOBLASTOMA, 74, 2023
2023
CHAPTER II. TEMPOROSPATIAL GENOMIC PROFILING IN GLIOBLASTOMA IDENTIFIES COMMONLY ALTERED CORE PATHWAYS UNDERLYING TUMOR PROGRESSION
MR Blomquist, SF Ensign, F D’Angelo, JJ Phillips
TARGETING RECURRENCE IN GLIOBLASTOMA, 43, 2023
2023
Multi-parametric MRI maps regional heterogeneity of high grade glioma phenotypes
M Flick, T Weiskittel, K Meng-Lin, F D'Angelo, F Caruso, S Ensign, ...
Cancer Research 83 (7_Supplement), 5621-5621, 2023
2023
Multiregional sampling of high grade glioma identifies regional biologic signatures
MR Blomquist, LS Hu, F D'Angelo, TM Weiskittel, FP Caruso, SPF Ensign, ...
Cancer Research 83 (7_Supplement), 1507-1507, 2023
2023
Role of TWEAK-Fn14 axis in driving immunosuppression in glioblastoma multiforme
A Beniwal, R Eghlimi, KD Alexander, MR Blomquist, N Tran
Cancer Research 83 (7_Supplement), 6442-6442, 2023
2023
Targeting Recurrence in Glioblastoma
MR Blomquist
College of Medicine-Mayo Clinic, 2023
2023
JAK-independent STAT5 signaling as a node of therapeutic vulnerability in glioblastoma
M Blomquist, S Tuncali, C Sereduk, J Kloss, J Loftus, N Tran
Cancer Research 82 (12_Supplement), 101-101, 2022
2022
ABT-414 RESISTANT GBM TUMORS HARBOR THE TEK S466I MUTATION AND EXHIBIT INCREASED STEMNESS
M Blomquist, T Noviello, F D'Angelo, C Sereduk, B Rabichow, A Miller, ...
NEURO-ONCOLOGY 23, 34-35, 2021
2021
Neuro-Oncology Advances
MR Blomquist, SF Ensign, F D’Angelo, JJ Phillips, M Ceccarelli, S Peng, ...
2020
WEE1 inhibition suppresses esophageal adenocarcinoma tumor growth both in vitro and in vivo
M Blomquist, VM Carson, RM Bremner, TG Whitsett, LJ Inge
Cancer Research 78 (13_Supplement), 1526-1526, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–19